High Throughput Screening Market

High Throughput Screening Market / HTS Market Size, Share & Trends by Offering (Instruments, Consumables (Reagents, Kits), Software, Services), Technology (Cell-based Assays, Lab-on-Chip, Label-free), Application (Drug Discovery, Life Sciences Research) - Global Forecast to 2029

Report Code: BT 2220 Jul, 2024, by marketsandmarkets.com

High Throughput Screening Market Size, Share & Trends

The size of global high throughput screening market in terms of revenue was estimated to be worth $28.8 billion in 2024 and is poised to reach $50.2 billion by 2029, growing at a CAGR of 11.8% from 2024 to 2029. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics.

There has been a substantial increase in the R&D funding which is supporting the innovation efforts for the development of novel therapeutics. Therefore, increasing drug discovery initiatives are leading to the growing adoption of high throughput screening (HTS) offerings and technologies. However, the high costs associated with the HTS instruments are anticipated to hinder market growth.

High Throughput Screening Market Trends

High-Throughput Screening  (HTS) Market

To know about the assumptions considered for the study, Request for Free Sample Report

Attractive Opportunities in the High Throughput Screening Market

High-Throughput Screening  (HTS) Market

High Throughput Screening Market Dynamics

DRIVER: The growing R&D funding and increasing public and private investments to aid market growth

There have been numerous grants and investments to support academic institutions and research organizations conducting therapeutic drug development research. These grants support drug discovery initiatives. Some instances include- in February 2024, the National Center for Advancing Translational Sciences (NCATS) awarded USD 7.8 million to the University of Pittsburgh School of Medicine (US) for developing a drug discovery system called the Pitt Translational Center for Micro-physiology Systems.

RESTRAINT: High costs associated with HTS instruments

HTS instruments include a wide range of equipment, such as automated liquid handling systems, robotic arms, microplate readers, high-resolution imaging systems, and associated software. The associated costs of these instruments are high. The high initial investment, however, can limit access to high-throughput screening technologies and reduce the rate of their adoption. Some of the instruments, such as flow cytometers and liquid handlers, are expensive. The price of a flow cytometer varies from USD 80,000 to USD 150,000 for sophisticated systems with high throughput. Moreover, liquid handling workstations are also premiumly priced. For instance, the price range falls between USD 100,000 to USD 500,000, depending on its sophistication. This is mainly due to the capital investment required and technological advancements and automation offered in the instruments.

OPPORTUNITY: Increasing adoption of high-throughput screening technologies in emerging markets

The emerging markets include developing economies across the globe. For instance, economies like China and India have observed significant growth in the pharmaceutical and biotechnology industries. Favorable government funding, supported by increasing investments in drug discovery initiatives utilizing HTS technologies, are factors creating increasing opportunities for players in the HTS market. Besides, the growing research applications of high-throughput screening technology in areas such as personalized medicine, genomics, and infectious disease research are supporting its adoption. Governments in emerging economies also prioritize education and training programs in high-throughput screening techniques to build a skilled workforce. Emerging markets create an environment that supports the adoption, development, and application of high-throughput screening technologies with such initiatives. For instance, the Indian government's Department of Biotechnology (DBT) supports the use of HTS technology in various fields, including agriculture and medicine.

CHALLENGE: Complexity in data management, assay development, and analysis

High throughput screening workflow generates large volumes of data from numerous biological or chemical assays. Managing this diverse dataset requires robust data management strategies to ensure accuracy and accessibility. Analyzing HTS data requires advanced statistical methods and bioinformatics tools to identify significant results. This adds to the complexity of data management. In addition, developing assays suitable for HTS involves optimizing conditions for rapid, simultaneous testing of numerous compounds. Ensuring reliability and reproducibility across high-throughput platforms is critical but challenging. Thus, this is a challenge in the growth of this market.

Global High Throughput Screening Market Ecosystem Analysis

The ecosystem for HTS consists of pharmaceutical & biotechnology companies, HTS service providers (screening services), instrument & reagent suppliers, academic & research institutions, technology providers, data management & analysis providers, regulatory authorities (ensuring compliance and safety), and collaborative networks promoting knowledge sharing and collaboration. These stakeholders interact and collaborate to drive the advancement of HTS technologies, enhance drug discovery processes, and develop new therapeutics.

High-Throughput Screening  (HTS) Market Ecosystem

The consumables segment dominated the high throughput screening industry by offerings:

Based on offerings, the high throughput screening market is segmented into consumables, instruments, services, and software. The consumables segment accounted for the largest share of the global high-throughput screening market in 2023. The large share of the segment can be attributed to factors such as the requirement for a wide range of reagents and kits in the HTS workflow, the need for the repeated purchase of consumables, unlike instruments, and a favorable drug discovery research funding/ investment scenario.

The Asia Pacific region is expected to register the fastest growth in the high throughput screening industry during the forecast period.

The Asia Pacific region is expected to account for the fastest-growing region of the high throughput screening market during the forecast period. The Asia Pacific region has a diverse pool of patient population, which adopts a wide range of therapeutics. This drives the need for the development and commercialization of novel therapeutics in the region. Thus, this in turn, supports the growth of the market in the region. Additionally, the region has a strong presence of key global pharmaceutical and biotechnology companies involved in innovation in the pharmaceutical industry.

High-Throughput Screening  (HTS) Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Key players in the high throughput screening market include Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Revvity, Inc. (US), Tecan Group Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), <a data-cke-saved-href=">Corning Incorporated (US), Mettler-Toledo International Inc. (US), Lonza (Switzerland), Waters Corporation (US), Sartorius AG (Germany), Eppendorf SE (Germany), Porvair PLC (UK), Greiner AG (Austria), Charles River Laboratories (US), Eurofins Scientific (Europe), Hamilton Company (US), Aurora Biomed Inc. (Canada), Gilson Incorporated (US), Brand GmbH+Co KG (Germany), BMG Labtech GmbH (Germany), DIANA Biotechnologies, A.S. (Czech Republic), Creative Biolabs. (US), HighRes Biosolutions. (US), Biomat Srl (Italy), AXXAM S.p.A. (Italy), Sygnature Discovery Limited (UK), and Crown Bioscience (US).

Scope of the High Throughput Screening Industry:

Report Metric

Details

Market Revenue in 2024

$28.8 billion

Projected Revenue by 2029

$50.2 billion

Revenue Rate

Poised to Grow at a CAGR of 11.8%

Market Driver

The growing R&D funding and increasing public and private investments to aid market growth

Market Opportunity

Increasing adoption of high-throughput screening technologies in emerging markets

This report categorizes the high throughput screening market into the following segments and subsegments:

By Offerings
  • Consumables
    • Reagents & Assay Kits
    • Laboratory Consumables
  • Instruments
    • Liquid Handling Systems
    • Detection Systems
    • Imaging Systems
    • Other Instruments
  • Services
  • Software
By Technology
  • Cell-based Assays
    • 2D Cell Culture
    • 3D Cell Culture
      • Scaffold-based Technology
        • Hydrogels
          • Animal-derived Hydrogels
            • Matrigel
            • Collagen
          • Synthetic Hydrogels
          • Alginate/Agarose
        • Inert Matrix/Solid Scaffolds
        • Micropatterned Surfaces
      • Scaffold-free Technology
        • Ultra-low Binding Plates
        • Hanging-drop Plates
        • Other Scaffold-free Technologies
    • Reporter-based Assays
    • Perfusion Cell Culture
  • Lab-on-a-Chip Technology (LOC)
  • Label-free Technology
By Application
  • Drug Discovery
  • Biochemical Screening
  • Life Sciences Research
  • Other Applications
By End User
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organizations (CROs)
  • Other End Users
By Region
  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific (APAC)
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • RoLATAM
  • Middle East
    • GCC
      • Saudi Arabia
      • UAE
      • Rest of GCC
  • Rest of Middle East
  • Africa

Recent Developments of High Throughput Screening Industry

  • In October 2023, Revvity Inc. (US), collaborated with SCIEX, a subsidiary of Danaher Corporation (US), to develop mass spectrometry solutions for newborn screening.
  • In May 2024, Bio-Rad Laboratories, Inc. (US) launched three new StarBright Red Dyes—StarBright Red 715, 775, and 815—providing greater choice and flexibility in conventional and full-spectrum multicolor flow cytometry panels.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TABLE OF CONTENTS
 
1 INTRODUCTION
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
 
4 PREMIUM INSIGHTS (Page No. - 68)
    4.1 HIGH-THROUGHPUT SCREENING (HTS) MARKET OVERVIEW 
    4.2 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET SHARE, BY OFFERING AND COUNTRY (2023) 
    4.3 HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING,  2024 VS. 2029 (USD MILLION) 
    4.4 HIGH-THROUGHPUT SCREENING (HTS) MARKET SHARE, BY END USER, 2023 
    4.5 HIGH-THROUGHPUT SCREENING (HTS) MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 
 
5 MARKET OVERVIEW (Page No. - 72)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
           5.2.1 DRIVERS
                    5.2.1.1 Growing adoption of open innovation models
                    5.2.1.2 Rising government funding and venture capital investments
                    5.2.1.3 Increasing R&D spending
                    5.2.1.4 Technological advancements
           5.2.2 RESTRAINTS
                    5.2.2.1 High cost of using HTS instruments
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Increasing adoption of HTS technologies in emerging markets
                    5.2.3.2 Growing research on novel therapeutics
                    5.2.3.3 Drug repurposing
           5.2.4 CHALLENGES
                    5.2.4.1 Lack of skilled operators
                    5.2.4.2 Complexities in data management, assay development, and analysis
    5.3 INDUSTRY TRENDS 
           5.3.1 ADOPTION OF PHENOTYPIC SCREENING
           5.3.2 AUTOMATION AND AI INTEGRATION
           5.3.3 RISE OF CRISPR TECHNOLOGY
           5.3.4 INTEGRATION OF SINGLE-CELL ANALYSIS TECHNOLOGIES
           5.3.5 REGULATORY CONSIDERATIONS
    5.4 TECHNOLOGY ANALYSIS 
           5.4.1 KEY TECHNOLOGIES
                    5.4.1.1 High-content screening/analysis
                    5.4.1.2 Label-free detection (surface plasmon resonance)
           5.4.2 COMPLEMENTARY TECHNOLOGIES
                    5.4.2.1 Microfluidics, organ-on-a-chip (OOC), and lab-on-a-chip (LOC)
                    5.4.2.2 Mass spectrometry (MS)
                    5.4.2.3 Flow cytometry
           5.4.3 ADJACENT TECHNOLOGIES
                    5.4.3.1 Fragment-based drug discovery
    5.5 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
    5.6 PRICING ANALYSIS 
    5.7 VALUE CHAIN ANALYSIS 
    5.8 SUPPLY CHAIN ANALYSIS 
    5.9 ECOSYSTEM ANALYSIS 
           5.9.1 HIGH-THROUGHPUT SCREENING MARKET: ROLE OF RAW MATERIAL VENDORS
           5.9.2 HIGH-THROUGHPUT SCREENING MARKET: ROLE OF PRODUCT & SERVICE PROVIDERS
           5.9.3 HIGH-THROUGHPUT SCREENING MARKET: ROLE OF END USERS
           5.9.4 HIGH-THROUGHPUT SCREENING MARKET: ROLE OF REGULATORY AUTHORITIES
    5.10 PATENT ANALYSIS 
    5.11 TRADE ANALYSIS 
           5.11.1 IMPORT DATA FOR SPECTROMETERS
           5.11.2 IMPORT DATA FOR MASS SPECTROMETERS
           5.11.3 EXPORT DATA FOR SPECTROMETERS
           5.11.4 EXPORT DATA FOR MASS SPECTROMETERS
    5.12 REGULATORY ANALYSIS 
           5.12.1 REGULATORY LANDSCAPE
                    5.12.1.1 US
                    5.12.1.2 Europe
                    5.12.1.3 Emerging markets
           5.12.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    5.13 PORTER’S FIVE FORCES ANALYSIS 
           5.13.1 INTENSITY OF COMPETITIVE RIVALRY
           5.13.2 BARGAINING POWER OF SUPPLIERS
           5.13.3 BARGAINING POWER OF BUYERS
           5.13.4 THREAT OF SUBSTITUTES
           5.13.5 THREAT OF NEW ENTRANTS
    5.14 KEY CONFERENCES & EVENTS, 2024–2025 
    5.15 KEY STAKEHOLDERS & BUYING CRITERIA 
           5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS OF HIGH-THROUGHPUT SCREENING PRODUCTS & SERVICES: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
           5.15.2 BUYING CRITERIA FOR HIGH-THROUGHPUT SCREENING PRODUCTS & SERVICES
           5.15.3 BUYING CRITERIA FOR HIGH-THROUGHPUT SCREENING PRODUCTS & SERVICES, BY END USER
 
6 HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING (Page No. - 117)
    6.1 INTRODUCTION 
    6.2 CONSUMABLES 
           6.2.1 REAGENTS & ASSAY KITS
                    6.2.1.1 Growing applications of HTS in drug discovery and life science research to support demand for consumables
           6.2.2 LABORATORY CONSUMABLES
                    6.2.2.1 Growing automation in high-throughput screening to propel market growth
    6.3 INSTRUMENTS 
           6.3.1 LIQUID HANDLING SYSTEMS
                    6.3.1.1 Ongoing technological advancements and automation to support market growth
           6.3.2 DETECTION SYSTEMS
                    6.3.2.1 High demand for high-throughput and sensitive detection systems to propel market
           6.3.3 IMAGING INSTRUMENTS
                    6.3.3.1 Advancements in high-content imaging systems to boost market
           6.3.4 OTHER INSTRUMENTS
    6.4 SERVICES 
           6.4.1 INCREASING ASSAY COMPLEXITIES AND GROWING NEED FOR COST-EFFECTIVE AND SPECIALIZED HTS EXPERTISE TO BOOST DEMAND
    6.5 SOFTWARE 
           6.5.1 ONGOING INTEGRATION OF ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING SOFTWARE TOOLS TO DRIVE MARKET
 
7 HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION (Page No. - 155)
    7.1 INTRODUCTION 
    7.2 DRUG DISCOVERY 
           7.2.1 GROWING DEMAND FOR MORE EFFECTIVE METHODS TO IDENTIFY NEW DRUG CANDIDATES TO SUPPORT MARKET GROWTH
    7.3 BIOCHEMICAL SCREENING 
           7.3.1 GROWING AWARENESS OF GENETIC DISORDERS AND SCREENING TESTS TO BOOST MARKET GROWTH
    7.4 LIFE SCIENCE RESEARCH 
           7.4.1 INCREASING INVESTMENTS IN STEM CELL RESEARCH TO CONTRIBUTE TO MARKET GROWTH
    7.5 OTHER APPLICATIONS 
 
8 HIGH-THROUGHPUT SCREENING MARKET, BY TECHNOLOGY (Page No. - 172)
    8.1 INTRODUCTION 
    8.2 CELL-BASED ASSAYS 
           8.2.1 2D CELL CULTURES
                    8.2.1.1 Cost-effectiveness of 2D cell cultures to promote market growth
           8.2.2 3D CELL CULTURES
                    8.2.2.1 Scaffold-based technology
                               8.2.2.1.1 Hydrogels
                                             8.2.2.1.1.1 Animal-derived hydrogels
                                                              8.2.2.1.1.1.1 Matrigel
                                                                                  8.2.2.1.1.1.1.1 Increasing applications of Matrigel in drug discovery and life science research to support market growth
                                                              8.2.2.1.1.1.2 Collagen
                                                                                  8.2.2.1.1.1.2.1 Growing demand for personalized medicines to support market growth
                                             8.2.2.1.1.2 Synthetic hydrogels
                                                              8.2.2.1.1.2.1 Better consistency and low risk of contamination to increase adoption and drive growth
                                             8.2.2.1.1.3 Alginate/Agarose
                                                              8.2.2.1.1.3.1 Ability of alginate to enhance accuracy and relevance to propel adoption
                               8.2.2.1.2 Inert matrices/Solid scaffolds
                                             8.2.2.1.2.1 Lack of native-like microenvironment and other disadvantages to restrain growth
                               8.2.2.1.3 Micropatterned surfaces
                                             8.2.2.1.3.1 Greater enzyme levels and drug reactivity to support adoption
                    8.2.2.2 Scaffold-free technology
                               8.2.2.2.1 Ultra-low-binding plates
                                             8.2.2.2.1.1 Demand for high-quality, low-background assays to boost market
                               8.2.2.2.2 Hanging-drop plates
                                             8.2.2.2.2.1 Cost-effectiveness to boost adoption among end users
                               8.2.2.2.3 Other scaffold-free technologies
           8.2.3 REPORTER-BASED ASSAYS
                    8.2.3.1 Growing applications of gene expression to support growth
           8.2.4 PERFUSION CELL CULTURES
                    8.2.4.1 Ongoing research to develop perfusion cell culture technology for drug discovery to support adoption
    8.3 LAB-ON-A-CHIP 
           8.3.1 INCREASING APPLICATIONS OF LAB-ON-A-CHIP TECHNOLOGY FOR HTS AND PRECISION MEDICINE DEVELOPMENT TO SUPPORT MARKET GROWTH
    8.4 LABEL-FREE TECHNOLOGY 
           8.4.1 ABILITY TO CONDUCT LABEL-FREE INVESTIGATION OF BIOMOLECULAR INTERACTIONS TO PROPEL ADOPTION
 
9 HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER (Page No. - 246)
    9.1 INTRODUCTION 
    9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 
           9.2.1 GROWING DEMAND FOR HTS SOLUTIONS IN LEAD DISCOVERY TO SUPPORT MARKET GROWTH
    9.3 ACADEMIC & RESEARCH INSTITUTES 
           9.3.1 GROWING ADOPTION OF HTS IN COLLABORATIVE ACADEMIC & RESEARCH ACTIVITIES TO AID MARKET GROWTH
    9.4 CONTRACT RESEARCH ORGANIZATIONS (CROS) 
           9.4.1 INCREASING OUTSOURCING OF R&D ACTIVITIES TO DRIVE MARKET GROWTH FOR CROS
    9.5 OTHER END USERS 
 
10 HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY REGION (Page No. - 262)
     10.1 INTRODUCTION 
     10.2 NORTH AMERICA 
             10.2.1 NORTH AMERICA: RECESSION IMPACT
             10.2.2 US
                        10.2.2.1 Presence of major research institutes and key pharmaceutical companies to support market growth
             10.2.3 CANADA
                        10.2.3.1 Government initiatives promoting research to support market growth
     10.3 EUROPE 
             10.3.1 EUROPE: RECESSION IMPACT
             10.3.2 GERMANY
                        10.3.2.1 Increasing research initiatives to boost market growth
             10.3.3 UK
                        10.3.3.1 Investments by pharmaceutical sponsors for drug discovery to support market
             10.3.4 FRANCE
                        10.3.4.1 Large pharmaceutical R&D expenditure to drive market growth
             10.3.5 ITALY
                        10.3.5.1 Strong collaborative research networks to fuel growth
             10.3.6 SPAIN
                        10.3.6.1 Rising R&D expenditure and increasing public-private partnerships to boost market
             10.3.7 REST OF EUROPE
     10.4 ASIA PACIFIC 
             10.4.1 ASIA PACIFIC: RECESSION IMPACT
             10.4.2 CHINA
                        10.4.2.1 Growing research and collaborations in field of drug discovery to support growth of market
             10.4.3 JAPAN
                        10.4.3.1 Growing focus on research and strategic collaborations to support market growth
             10.4.4 INDIA
                        10.4.4.1 Developing healthcare industry and ongoing government initiatives to create favorable opportunities for market players
             10.4.5 AUSTRALIA
                        10.4.5.1 Growing pharmaceutical industry to create favorable opportunities for market players
             10.4.6 SOUTH KOREA
                        10.4.6.1 Growing pharmaceutical industry to favor market growth
             10.4.7 REST OF ASIA PACIFIC (ROAPAC)
     10.5 LATIN AMERICA 
             10.5.1 LATIN AMERICA: RECESSION IMPACT
             10.5.2 BRAZIL
                        10.5.2.1 Gradual growth in research to contribute to growth
             10.5.3 MEXICO
                        10.5.3.1 Favorable government support to contribute to growth
             10.5.4 REST OF LATIN AMERICA
     10.6 MIDDLE EAST 
             10.6.1 MIDDLE EAST: RECESSION IMPACT
             10.6.2 GCC COUNTRIES
                        10.6.2.1 Saudi Arabia
                                     10.6.2.1.1 Growing pharmaceuticals industry to support market growth
                        10.6.2.2 UAE
                                     10.6.2.2.1 High R&D expenditure and advanced healthcare infrastructure to boost market growth
                        10.6.2.3 Rest of GCC Countries
     10.7 AFRICA 
             10.7.1 INCREASING FUNDING AND PARTNERSHIPS IN RESEARCH SECTOR TO AID MARKET GROWTH
             10.7.2 AFRICA: RECESSION IMPACT
 
11 COMPETITIVE LANDSCAPE (Page No. - 404)
     11.1 OVERVIEW 
     11.2 KEY PLAYER STRATEGY/RIGHT TO WIN 
             11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN HIGH-THROUGHPUT SCREENING (HTS) MARKET
     11.3 REVENUE ANALYSIS 
     11.4 MARKET SHARE ANALYSIS 
     11.5 COMPANY EVALUATION QUADRANT: KEY PLAYERS, 2023 
             11.5.1 STARS
             11.5.2 EMERGING LEADERS
             11.5.3 PERVASIVE PLAYERS
             11.5.4 PARTICIPANTS
             11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
                        11.5.5.1 Company footprint
                        11.5.5.2 Offering footprint
                        11.5.5.3 Application footprint
                        11.5.5.4 Region footprint
     11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 
             11.6.1 PROGRESSIVE COMPANIES
             11.6.2 RESPONSIVE COMPANIES
             11.6.3 DYNAMIC COMPANIES
             11.6.4 STARTING BLOCKS
             11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
     11.7 COMPANY VALUATION & FINANCIAL METRICS 
             11.7.1 FINANCIAL METRICS
             11.7.2 COMPANY VALUATION
     11.8 BRAND/PRODUCT COMPARISON 
     11.9 COMPETITIVE SCENARIO 
             11.9.1 PRODUCT LAUNCHES
             11.9.2 DEALS
             11.9.3 EXPANSIONS
 
12 COMPANY PROFILES (Page No. - 427)
     12.1 KEY PLAYERS 
             12.1.1 THERMO FISHER SCIENTIFIC INC.
                        12.1.1.1 Business overview
                        12.1.1.2 Products & services offered
                        12.1.1.3 Recent developments
                                     12.1.1.3.1 Product launches & approvals
                                     12.1.1.3.2 Deals
                                     12.1.1.3.3 Expansions
                        12.1.1.4 MnM view
                                     12.1.1.4.1 Right to win
                                     12.1.1.4.2 Strategic choices
                                     12.1.1.4.3 Weaknesses & competitive threats
             12.1.2 AGILENT TECHNOLOGIES, INC.
                        12.1.2.1 Business overview
                        12.1.2.2 Products & services offered
                        12.1.2.3 Recent developments
                                     12.1.2.3.1 Product launches & upgrades
                                     12.1.2.3.2 Deals
                        12.1.2.4 MnM view
                                     12.1.2.4.1 Right to win
                                     12.1.2.4.2 Strategic choices
                                     12.1.2.4.3 Weaknesses & competitive threats
             12.1.3 MERCK KGAA
                        12.1.3.1 Business overview
                        12.1.3.2 Products & services offered
                        12.1.3.3 Recent developments
                                     12.1.3.3.1 Other developments
                        12.1.3.4 MnM view
                                     12.1.3.4.1 Right to win
                                     12.1.3.4.2 Strategic choices
                                     12.1.3.4.3 Weaknesses & competitive threats
             12.1.4 DANAHER CORPORATION
                        12.1.4.1 Business overview
                        12.1.4.2 Products & services offered
                        12.1.4.3 Recent developments
                                     12.1.4.3.1 Product & service launches
                                     12.1.4.3.2 Deals
                                     12.1.4.3.3 Expansions
             12.1.5 REVVITY, INC.
                        12.1.5.1 Business overview
                        12.1.5.2 Products & services offered
                        12.1.5.3 Recent developments
                                     12.1.5.3.1 Product launches
                                     12.1.5.3.2 Deals
             12.1.6 TECAN GROUP LTD.
                        12.1.6.1 Business overview
                        12.1.6.2 Products & service offered
                        12.1.6.3 Recent developments
                                     12.1.6.3.1 Product launches & upgrades
                                     12.1.6.3.2 Deals
             12.1.7 BIO-RAD LABORATORIES, INC.
                        12.1.7.1 Business overview
                        12.1.7.2 Products & services offered
                        12.1.7.3 Recent developments
                                     12.1.7.3.1 Product launches
             12.1.8 CORNING INCORPORATED
                        12.1.8.1 Business overview
                        12.1.8.2 Products & services offered
                        12.1.8.3 Recent developments
                                     12.1.8.3.1 Product launches
             12.1.9 METTLER-TOLEDO INTERNATIONAL INC.
                        12.1.9.1 Business overview
                        12.1.9.2 Products & services offered
                        12.1.9.3 Recent developments
                                     12.1.9.3.1 Product launches
             12.1.10 LONZA GROUP
                        12.1.10.1 Business overview
                        12.1.10.2 Products & services offered
                        12.1.10.3 Recent developments
                                     12.1.10.3.1 Deals
             12.1.11 WATERS CORPORATION
                        12.1.11.1 Business overview
                        12.1.11.2 Products & services offered
                        12.1.11.3 Recent developments
                                     12.1.11.3.1 Product launches
                                     12.1.11.3.2 Deals
             12.1.12 SARTORIUS AG
                        12.1.12.1 Business overview
                        12.1.12.2 Products & services offered
                        12.1.12.3 Recent developments
                                     12.1.12.3.1 Product launches
             12.1.13 EPPENDORF SE
                        12.1.13.1 Business overview
                        12.1.13.2 Products & services offered
                        12.1.13.3 Recent developments
                                     12.1.13.3.1 Deals
                                     12.1.13.3.2 Expansions
             12.1.14 PORVAIR PLC
                        12.1.14.1 Business overview
                        12.1.14.2 Products & services offered
             12.1.15 GREINER AG
                        12.1.15.1 Business overview
                        12.1.15.2 Products & services offered
             12.1.16 CHARLES RIVER LABORATORIES
                        12.1.16.1 Business overview
                        12.1.16.2 products & services offered
                        12.1.16.3 Recent developments
                                     12.1.16.3.1 Deals
             12.1.17 EUROFINS SCIENTIFIC
                        12.1.17.1 Business overview
                        12.1.17.2 Products & services offered
                        12.1.17.3 Recent developments
                                     12.1.17.3.1 Service launches
                                     12.1.17.3.2 Deals
                                     12.1.17.3.3 Expansions
             12.1.18 HAMILTON COMPANY
                        12.1.18.1 Business overview
                        12.1.18.2 Products & services offered
                        12.1.18.3 Recent developments
                                     12.1.18.3.1 Product launches
                                     12.1.18.3.2 Deals
             12.1.19 AURORA BIOMED INC.
                        12.1.19.1 Business overview
                        12.1.19.2 Products & services offered
             12.1.20 GILSON INCORPORATED
                        12.1.20.1 Business overview
                        12.1.20.2 Products & services offered
                        12.1.20.3 Recent developments
                                     12.1.20.3.1 Product launches
                                     12.1.20.3.2 Deals
             12.1.21 BRAND GMBH + CO KG
                        12.1.21.1 Business overview
                        12.1.21.2 Products & services offered
                        12.1.21.3 Recent developments
                                     12.1.21.3.1 Expansions
     12.2 OTHER PLAYERS 
             12.2.1 BMG LABTECH GMBH
             12.2.2 DIANA BIOTECHNOLOGIES, A.S.
             12.2.3 CREATIVE BIOLABS
             12.2.4 HIGHRES BIOSOLUTIONS
             12.2.5 BIOMAT SRL
             12.2.6 AXXAM S.P.A.
             12.2.7 SYGNATURE DISCOVERY LIMITED
             12.2.8 CROWN BIOSCIENCE
 
13 APPENDIX (Page No. - 538)
     13.1 DISCUSSION GUIDE 
     13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     13.3 CUSTOMIZATION OPTIONS 
     13.4 RELATED REPORTS 
     13.5 AUTHOR DETAILS 
 
 
LIST OF TABLES (731 TABLES)
 
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2028 (% GROWTH)
TABLE 2 HIGH-THROUGHPUT SCREENING MARKET: IMPACT ANALYSIS
TABLE 3 AVERAGE SELLING PRICE FOR HIGH-THROUGHPUT SCREENING PRODUCTS, 2023
TABLE 4 AVERAGE SELLING PRICE FOR HIGH-THROUGHPUT SCREENING PRODUCTS, BY REGION
TABLE 5 INDICATIVE PRICING FOR HIGH-THROUGHPUT SCREENING PRODUCTS, BY REGION, 2021–2023 (USD)
TABLE 6 HIGH-THROUGHPUT SCREENING MARKET: ROLE OF RAW MATERIAL VENDORS
TABLE 7 HIGH-THROUGHPUT SCREENING MARKET: ROLE OF PRODUCT & SERVICE PROVIDERS
TABLE 8 HIGH-THROUGHPUT SCREENING MARKET: ROLE OF END USERS
TABLE 9 HIGH-THROUGHPUT SCREENING MARKET: ROLE OF REGULATORY AUTHORITIES
TABLE 10 PATENTS FILED, BY DOCUMENT TYPE, 2012–2023
TABLE 11 INDICATIVE LIST OF PATENTS IN HIGH-THROUGHPUT SCREENING MARKET
TABLE 12 IMPORT DATA FOR SPECTROMETERS, BY COUNTRY, 2019–2023 (USD THOUSAND)
TABLE 13 IMPORT VOLUME DATA FOR SPECTROMETERS, BY COUNTRY, 2019–2023 (UNITS)
TABLE 14 IMPORT DATA FOR MASS SPECTROMETERS, BY COUNTRY, 2022–2023 (USD THOUSAND)
TABLE 15 IMPORT VOLUME DATA FOR MASS SPECTROMETERS, BY COUNTRY, 2022–2023 (UNITS)
TABLE 16 EXPORT DATA FOR SPECTROMETERS, BY COUNTRY, 2019–2023 (USD THOUSAND)
TABLE 17 EXPORT VOLUME DATA FOR SPECTROMETERS, BY COUNTRY, 2019–2023 (UNITS)
TABLE 18 EXPORT DATA FOR MASS SPECTROMETERS, BY COUNTRY, 2019–2023 (USD THOUSAND)
TABLE 19 EXPORT VOLUME DATA FOR MASS SPECTROMETERS, BY COUNTRY, 2019–2023 (UNITS)
TABLE 20 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 21 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 22 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 23 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 24 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 25 HIGH-THROUGHPUT SCREENING MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 26 HIGH-THROUGHPUT SCREENING MARKET: LIST OF CONFERENCES & EVENTS
TABLE 27 HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 28 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 29 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 30 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 31 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 32 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 33 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 34 HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 35 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REAGENTS & ASSAY KITS, BY REGION, 2022–2029 (USD MILLION)
TABLE 36 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REAGENTS & ASSAY KITS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 37 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REAGENTS & ASSAY KITS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 38 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REAGENTS & ASSAY KITS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 39 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REAGENTS & ASSAY KITS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 40 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REAGENTS & ASSAY KITS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 41 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REAGENTS & ASSAY KITS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 42 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABORATORY CONSUMABLES, BY REGION, 2022–2029 (USD MILLION)
TABLE 43 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABORATORY CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 44 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABORATORY CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 45 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABORATORY CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 46 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABORATORY CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 47 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABORATORY CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 48 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABORATORY CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 49 HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 50 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 51 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 52 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 53 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 54 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 55 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 56 HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 57 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIQUID HANDLING SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
TABLE 58 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIQUID HANDLING SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 59 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIQUID HANDLING SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 60 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIQUID HANDLING SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 61 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIQUID HANDLING SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 62 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIQUID HANDLING SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 63 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIQUID HANDLING SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 64 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DETECTION SYSTEMS,  BY REGION, 2022–2029 (USD MILLION)
TABLE 65 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DETECTION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 66 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DETECTION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 67 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DETECTION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 68 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DETECTION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 69 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DETECTION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 70 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DETECTION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 71 HIGH-THROUGHPUT SCREENING MARKET FOR FLOW CYTOMETRY INSTRUMENTS FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022–2029 (UNITS)
TABLE 72 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR IMAGING INSTRUMENTS, BY REGION, 2022–2029 (USD MILLION)
TABLE 73 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR IMAGING INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 74 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR IMAGING INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 75 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR IMAGING INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 76 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR IMAGING INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 77 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR IMAGING INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 78 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR IMAGING INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 79 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER INSTRUMENTS, BY REGION, 2022–2029 (USD MILLION)
TABLE 80 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 81 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 82 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 83 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 84 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 85 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 86 HIGH-THROUGHPUT SCREENING (HTS) SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 87 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 88 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 89 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 90 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 91 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 92 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 93 HIGH-THROUGHPUT SCREENING (HTS) SOFTWARE MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 94 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 95 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 96 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) SOFTWARE MARKET,  BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 97 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 98 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 99 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 100 HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 101 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DRUG DISCOVERY APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 102 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 103 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 104 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 105 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 106 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 107 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 108 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR BIOCHEMICAL SCREENING APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 109 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR BIOCHEMICAL SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 110 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR BIOCHEMICAL SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 111 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR BIOCHEMICAL SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 112 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR BIOCHEMICAL SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 113 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR BIOCHEMICAL SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 114 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR BIOCHEMICAL SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 115 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIFE SCIENCE RESEARCH APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 116 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIFE SCIENCE RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 117 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIFE SCIENCE RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 118 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIFE SCIENCE RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 119 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIFE SCIENCE RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 120 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIFE SCIENCE RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 121 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIFE SCIENCE RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 122 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 123 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 124 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 125 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 126 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 127 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 128 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 129 HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 130 COMPARISON OF 2D AND 3D CELL CULTURES
TABLE 131 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 132 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY REGION, 2022–2029 (USD MILLION)
TABLE 133 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 134 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 135 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 136 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 137 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 138 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 139 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 2D CELL CULTURES, BY REGION, 2022–2029 (USD MILLION)
TABLE 140 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 2D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 141 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 2D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 142 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 2D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 143 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 2D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 144 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 2D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 145 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 2D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 146 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 147 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY REGION, 2022–2029 (USD MILLION)
TABLE 148 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 149 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 150 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 151 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 152 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 153 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 154 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 155 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY REGION, 2022–2029 (USD MILLION)
TABLE 156 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 157 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 158 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 159 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 160 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 161 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 162 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 163 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY REGION, 2022–2029 (USD MILLION)
TABLE 164 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 165 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 166 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 167 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 168 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 169 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 170 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 171 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY REGION, 2022–2029 (USD MILLION)
TABLE 172 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 173 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 174 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 175 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 176 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 177 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 178 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MATRIGEL, BY REGION, 2022–2029 (USD MILLION)
TABLE 179 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MATRIGEL, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 180 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MATRIGEL, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 181 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MATRIGEL, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 182 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MATRIGEL, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 183 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MATRIGEL,  BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 184 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MATRIGEL, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 185 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR COLLAGEN, BY REGION, 2022–2029 (USD MILLION)
TABLE 186 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR COLLAGEN, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 187 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR COLLAGEN, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 188 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR COLLAGEN, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 189 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR COLLAGEN, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 190 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR COLLAGEN, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 191 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR COLLAGEN, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 192 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SYNTHETIC HYDROGELS, BY REGION, 2022–2029 (USD MILLION)
TABLE 193 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SYNTHETIC HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 194 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SYNTHETIC HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 195 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SYNTHETIC HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 196 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SYNTHETIC HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 197 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SYNTHETIC HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 198 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SYNTHETIC HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 199 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ALGINATE/AGAROSE, BY REGION, 2022–2029 (USD MILLION)
TABLE 200 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ALGINATE/AGAROSE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 201 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ALGINATE/AGAROSE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 202 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ALGINATE/AGAROSE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 203 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ALGINATE/AGAROSE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 204 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ALGINATE/AGAROSE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 205 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ALGINATE/AGAROSE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 206 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR INERT MATRICES/SOLID SCAFFOLDS, BY REGION, 2022–2029 (USD MILLION)
TABLE 207 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR INERT MATRICES/SOLID SCAFFOLDS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 208 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR INERT MATRICES/SOLID SCAFFOLDS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 209 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR INERT MATRICES/SOLID SCAFFOLDS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 210 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR INERT MATRICES/SOLID SCAFFOLDS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 211 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR INERT MATRICES/SOLID SCAFFOLDS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 212 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR INERT MATRICES/SOLID SCAFFOLDS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 213 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MICROPATTERNED SURFACES, BY REGION, 2022–2029 (USD MILLION)
TABLE 214 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 215 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 216 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 217 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 218 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 219 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 220 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 221 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY REGION, 2022–2029 (USD MILLION)
TABLE 222 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 223 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 224 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 225 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 226 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 227 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 228 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ULTRA-LOW-BINDING PLATES, BY REGION, 2022–2029 (USD MILLION)
TABLE 229 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ULTRA-LOW-BINDING PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 230 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ULTRA-LOW-BINDING PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 231 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ULTRA-LOW-BINDING PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 232 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ULTRA-LOW-BINDING PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 233 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ULTRA-LOW-BINDING PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 234 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ULTRA-LOW-BINDING PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 235 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HANGING-DROP PLATES, BY REGION, 2022–2029 (USD MILLION)
TABLE 236 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HANGING-DROP PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 237 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HANGING-DROP PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 238 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HANGING-DROP PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 239 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HANGING-DROP PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 240 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HANGING-DROP PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 241 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HANGING-DROP PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 242 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER SCAFFOLD-FREE TECHNOLOGIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 243 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER SCAFFOLD-FREE TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 244 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER SCAFFOLD-FREE TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 245 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER SCAFFOLD-FREE TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 246 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER SCAFFOLD-FREE TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 247 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER SCAFFOLD-FREE TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 248 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER SCAFFOLD-FREE TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 249 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REPORTER-BASED ASSAYS, BY REGION, 2022–2029 (USD MILLION)
TABLE 250 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REPORTER-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 251 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REPORTER-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 252 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REPORTER-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 253 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REPORTER-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 254 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REPORTER-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 255 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REPORTER-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 256 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PERFUSION CELL CULTURES, BY REGION, 2022–2029 (USD MILLION)
TABLE 257 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PERFUSION CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 258 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PERFUSION CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 259 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PERFUSION CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 260 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PERFUSION CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 261 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PERFUSION CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 262 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PERFUSION CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 263 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LAB-ON-A-CHIP TECHNOLOGY, BY REGION, 2022–2029 (USD MILLION)
TABLE 264 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LAB-ON-A-CHIP TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 265 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LAB-ON-A-CHIP TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 266 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LAB-ON-A-CHIP TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 267 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LAB-ON-A-CHIP TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 268 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LAB-ON-A-CHIP TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 269 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LAB-ON-A-CHIP TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 270 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABEL-FREE TECHNOLOGY, BY REGION, 2022–2029 (USD MILLION)
TABLE 271 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABEL-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 272 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABEL-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 273 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET LABEL-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 274 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABEL-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 275 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABEL-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 276 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABEL-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 277 HIGH-THROUGHPUT SCREENING MARKET (HTS), BY END USER, 2022–2029 (USD MILLION)
TABLE 278 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 279 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 280 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 281 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 282 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 283 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 284 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 285 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
TABLE 286 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 287 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 288 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 289 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 290 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 291 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 292 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 293 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 294 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 295 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 296 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 297 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 298 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 299 HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
TABLE 300 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 301 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 302 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 303 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 304 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 305 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 306 HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 307 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 308 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 309 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 310 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 311 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 312 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 313 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 314 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 315 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 316 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 317 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 318 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 319 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 320 US: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 321 US: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 322 US: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 323 US: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 324 US: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 325 US: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 326 US: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 327 US: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 328 US: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 329 US: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 330 US: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 331 US: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 332 CANADA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 333 CANADA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 334 CANADA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 335 CANADA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 336 CANADA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 337 CANADA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 338 CANADA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 339 CANADA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 340 CANADA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 341 CANADA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 342 CANADA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 343 CANADA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 344 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 345 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 346 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 347 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 348 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 349 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 350 EUROPE HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 351 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 352 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 353 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 354 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 355 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 356 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 357 GERMANY: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 358 GERMANY: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 359 GERMANY: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 360 GERMANY: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 361 GERMANY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 362 GERMANY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 363 GERMANY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 364 GERMANY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 365 GERMANY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 366 GERMANY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 367 GERMANY: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 368 GERMANY: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 369 UK: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 370 UK: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 371 UK: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 372 UK: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 373 UK: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 374 UK: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 375 UK: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 376 UK: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 377 UK: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 378 UK: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 379 UK: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 380 UK: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 381 FRANCE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 382 FRANCE: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 383 FRANCE: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 384 FRANCE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 385 FRANCE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 386 FRANCE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 387 FRANCE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 388 FRANCE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 389 FRANCE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 390 FRANCE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 391 FRANCE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 392 FRANCE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 393 ITALY: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 394 ITALY: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 395 ITALY: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 396 ITALY: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 397 ITALY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 398 ITALY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 399 ITALY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 400 ITALY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 401 ITALY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 402 ITALY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 403 ITALY: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 404 ITALY: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 405 SPAIN: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 406 SPAIN: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 407 SPAIN: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 408 SPAIN: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 409 SPAIN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 410 SPAIN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 411 SPAIN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 412 SPAIN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 413 SPAIN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 414 SPAIN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 415 SPAIN: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 416 SPAIN: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 417 REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 418 REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 419 REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 420 REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 421 REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 422 REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 423 REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 424 REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 425 REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 426 REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 427 REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 428 REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 429 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 430 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 431 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 432 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET,  BY TYPE, 2022–2029 (USD MILLION)
TABLE 433 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 434 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 435 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 436 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 437 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 438 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 439 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 440 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 441 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 442 CHINA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 443 CHINA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 444 CHINA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 445 CHINA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 446 CHINA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 447 CHINA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 448 CHINA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 449 CHINA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 450 CHINA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 451 CHINA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 452 CHINA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 453 CHINA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 454 JAPAN: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 455 JAPAN: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 456 JAPAN: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 457 JAPAN: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 458 JAPAN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 459 JAPAN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 460 JAPAN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 461 JAPAN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 462 JAPAN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 463 JAPAN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 464 JAPAN: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 465 JAPAN: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 466 INDIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 467 INDIA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 468 INDIA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 469 INDIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY,  2022–2029 (USD MILLION)
TABLE 470 INDIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 471 INDIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 472 INDIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 473 INDIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 474 INDIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 475 INDIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 476 INDIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 477 INDIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 478 AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 479 AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 480 AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 481 AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 482 AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 483 AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 484 AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 485 AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS,  BY TYPE, 2022–2029 (USD MILLION)
TABLE 486 AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 487 AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 488 AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 489 AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 490 SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 491 SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 492 SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 493 SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 494 SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 495 SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 496 SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 497 SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 498 SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 499 SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 500 SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 501 SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 502 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 503 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 504 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 505 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 506 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 507 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 508 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 509 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 510 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 511 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 512 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 513 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 514 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 515 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 516 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 517 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 518 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 519 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 520 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 521 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 522 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 523 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 524 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 525 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 526 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 527 BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 528 BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 529 BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 530 BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 531 BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 532 BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 533 BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 534 BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 535 BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 536 BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 537 BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 538 BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 539 MEXICO: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 540 MEXICO: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 541 MEXICO: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 542 MEXICO: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 543 MEXICO: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 544 MEXICO: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 545 MEXICO: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 546 MEXICO: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 547 MEXICO: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 548 MEXICO: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 549 MEXICO: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 550 MEXICO: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 551 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 552 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 553 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 554 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 555 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 556 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 557 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET  FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 558 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET  FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 559 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 560 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 561 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 562 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 563 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 564 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 565 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 566 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 567 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 568 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 569 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 570 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 571 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 572 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 573 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 574 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 575 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 576 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 577 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 578 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 579 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 580 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 581 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 582 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 583 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 584 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 585 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 586 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 587 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 588 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 589 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 590 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 591 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 592 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 593 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 594 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 595 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 596 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 597 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 598 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 599 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 600 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 601 UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) MARKET,  BY OFFERING, 2022–2029 (USD MILLION)
TABLE 602 UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 603 UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 604 UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 605 UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 606 UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 607 UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 608 UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 609 UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 610 UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 611 UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 612 UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) MARKET,  BY END USER, 2022–2029 (USD MILLION)
TABLE 613 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 614 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 615 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 616 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 617 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 618 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 619 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 620 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 621 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 622 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 623 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 624 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET,  BY END USER, 2022–2029 (USD MILLION)
TABLE 625 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 626 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 627 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 628 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 629 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 630 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 631 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 632 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 633 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 634 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 635 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 636 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 637 AFRICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 638 AFRICA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 639 AFRICA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 640 AFRICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 641 AFRICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 642 AFRICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 643 AFRICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 644 AFRICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 645 AFRICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 646 AFRICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 647 AFRICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 648 AFRICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 649 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN HIGH-THROUGHPUT SCREENING MARKET
TABLE 650 HIGH-THROUGHPUT SCREENING (HTS) MARKET: DEGREE OF COMPETITION
TABLE 651 HIGH-THROUGHPUT SCREENING (HTS) MARKET: OFFERING FOOTPRINT
TABLE 652 HIGH-THROUGHPUT SCREENING (HTS) MARKET: APPLICATION FOOTPRINT
TABLE 653 HIGH-THROUGHPUT SCREENING (HTS) MARKET: REGION FOOTPRINT
TABLE 654 HIGH-THROUGHPUT SCREENING (HTS) MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
TABLE 655 HIGH-THROUGHPUT SCREENING (HTS) MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
TABLE 656 HIGH-THROUGHPUT SCREENING (HTS) MARKET: PRODUCT LAUNCHES, JANUARY 2021–MAY 2024
TABLE 657 HIGH-THROUGHPUT SCREENING (HTS) MARKET: DEALS, JANUARY 2021–MAY 2024
TABLE 658 HIGH-THROUGHPUT SCREENING (HTS) MARKET: EXPANSIONS,  JANUARY 2021–MAY 2024
TABLE 659 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
TABLE 660 THERMO FISHER SCIENTIFIC INC.: PRODUCTS & SERVICES OFFERED
TABLE 661 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES & APPROVALS
TABLE 662 THERMO FISHER SCIENTIFIC INC.: DEALS
TABLE 663 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS
TABLE 664 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
TABLE 665 AGILENT TECHNOLOGIES, INC.: PRODUCTS & SERVICES OFFERED
TABLE 666 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES & UPGRADES
TABLE 667 AGILENT TECHNOLOGIES, INC.: DEALS
TABLE 668 MERCK KGAA: BUSINESS OVERVIEW
TABLE 669 MERCK KGAA: PRODUCTS & SERVICES OFFERED
TABLE 670 MERCK KGAA: OTHER DEVELOPMENTS
TABLE 671 DANAHER CORPORATION: BUSINESS OVERVIEW
TABLE 672 DANAHER CORPORATION: PRODUCTS & SERVICES OFFERED
TABLE 673 DANAHER CORPORATION: PRODUCT & SERVICE LAUNCHES
TABLE 674 DANAHER CORPORATION: DEALS
TABLE 675 DANAHER CORPORATION: EXPANSIONS
TABLE 676 REVVITY, INC.: BUSINESS OVERVIEW
TABLE 677 REVVITY INC.: PRODUCTS & SERVICES OFFERED
TABLE 678 REVVITY, INC.: PRODUCT LAUNCHES
TABLE 679 REVVITY, INC.: DEALS
TABLE 680 TECAN GROUP LTD.: BUSINESS OVERVIEW
TABLE 681 TECAN GROUP LTD.: PRODUCTS & SERVICES OFFERED
TABLE 682 TECAN GROUP LTD.: PRODUCT LAUNCHES & UPGRADES
TABLE 683 TECAN GROUP LTD.: DEALS
TABLE 684 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
TABLE 685 BIO-RAD LABORATORIES, INC.: PRODUCTS & SERVICES OFFERED
TABLE 686 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES
TABLE 687 CORNING INCORPORATED: BUSINESS OVERVIEW
TABLE 688 CORNING INCORPORATED: PRODUCTS & SERVICES OFFERED
TABLE 689 CORNING INCORPORATED: PRODUCT LAUNCHES
TABLE 690 METTLER-TOLEDO INTERNATIONAL INC.: BUSINESS OVERVIEW
TABLE 691 METTLER-TOLEDO INTERNATIONAL INC.: PRODUCTS & SERVICES OFFERED
TABLE 692 METTLER-TOLEDO INTERNATIONAL INC.: PRODUCT LAUNCHES
TABLE 693 LONZA GROUP: BUSINESS OVERVIEW
TABLE 694 LONZA GROUP: PRODUCTS & SERVICES OFFERED
TABLE 695 LONZA GROUP: DEALS
TABLE 696 WATERS CORPORATION: BUSINESS OVERVIEW
TABLE 697 WATERS CORPORATION: PRODUCTS & SERVICES OFFERED
TABLE 698 WATERS CORPORATION: PRODUCT LAUNCHES
TABLE 699 WATERS CORPORATION: DEALS
TABLE 700 SARTORIUS AG: BUSINESS OVERVIEW
TABLE 701 SARTORIUS AG: PRODUCTS & SERVICES OFFERED
TABLE 702 SARTORIUS AG: PRODUCT LAUNCHES
TABLE 703 EPPENDORF SE: BUSINESS OVERVIEW
TABLE 704 EPPENDORF SE: PRODUCTS & SERVICES OFFERED
TABLE 705 EPPENDORF SE: DEALS
TABLE 706 EPPENDORF SE: EXPANSIONS
TABLE 707 PORVAIR PLC: BUSINESS OVERVIEW
TABLE 708 PORVAIR PLC: PRODUCTS & SERVICES OFFERED
TABLE 709 GREINER AG: BUSINESS OVERVIEW
TABLE 710 GREINER AG: PRODUCTS & SERVICES OFFERED
TABLE 711 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: BUSINESS OVERVIEW
TABLE 712 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: PRODUCTS & SERVICES OFFERED
TABLE 713 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: DEALS
TABLE 714 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW
TABLE 715 EUROFINS SCIENTIFIC: PRODUCTS & SERVICES OFFERED
TABLE 716 EUROFINS SCIENTIFIC: SERVICE LAUNCHES
TABLE 717 EUROFINS SCIENTIFIC: DEALS
TABLE 718 EUROFINS SCIENTIFIC: EXPANSIONS
TABLE 719 HAMILTON COMPANY: BUSINESS OVERVIEW
TABLE 720 HAMILTON COMPANY: PRODUCTS & SERVICES OFFERED
TABLE 721 HAMILTON COMPANY: PRODUCT LAUNCHES
TABLE 722 HAMILTON COMPANY: DEALS
TABLE 723 AURORA BIOMED INC.: BUSINESS OVERVIEW
TABLE 724 AURORA BIOMED INC.: PRODUCTS & SERVICES OFFERED
TABLE 725 GILSON INCORPORATED: BUSINESS OVERVIEW
TABLE 726 GILSON INCORPORATED: PRODUCTS & SERVICES OFFERED
TABLE 727 GILSON INCORPORATED.: PRODUCT LAUNCHES
TABLE 728 GILSON INCORPORATED: DEALS
TABLE 729 BRAND GMBH + CO KG: BUSINESS OVERVIEW
TABLE 730 BRAND GMBH + CO KG: PRODUCTS & SERVICES OFFERED
TABLE 731 BRAND GMBH + CO KG: EXPANSIONS
 
 
LIST OF FIGURES (58 FIGURES)
 
FIGURE 1 HIGH-THROUGHPUT SCREENING (HTS) MARKET SEGMENTATION
FIGURE 2 RESEARCH DESIGN
FIGURE 3 HIGH-THROUGHPUT SCREENING (HTS) MARKET: BREAKDOWN OF PRIMARIES
FIGURE 4 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS, 2023
FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2023
FIGURE 6 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS, 2023
FIGURE 7 MARKET VALIDATION FROM PRIMARY EXPERTS
FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
FIGURE 9 HIGH-THROUGHPUT SCREENING (HTS) MARKET: CAGR PROJECTIONS, 2024–2029
FIGURE 10 HIGH-THROUGHPUT SCREENING (HTS) MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 11 DATA TRIANGULATION METHODOLOGY
FIGURE 12 HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2024 VS. 2029 (USD MILLION)
FIGURE 13 HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY,  2024 VS. 2029 (USD MILLION)
FIGURE 14 HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
FIGURE 15 HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
FIGURE 16 GEOGRAPHICAL SNAPSHOT: HIGH-THROUGHPUT SCREENING (HTS) MARKET
FIGURE 17 GROWING ADOPTION OF OPEN INNOVATIVE MODELS IN PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DRIVE MARKET GROWTH
FIGURE 18 CONSUMABLES DOMINATED NORTH AMERICAN HIGH-THROUGHPUT SCREENING (HTS) MARKET IN 2023
FIGURE 19 CONSUMABLES TO CONTINUE TO DOMINATE MARKET BY 2029
FIGURE 20 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
FIGURE 21 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE IN HIGH-THROUGHPUT SCREENING (HTS) MARKET FROM 2024 TO 2029
FIGURE 22 HIGH-THROUGHPUT SCREENING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 23 RISING GLOBAL PHARMACEUTICAL R&D SPENDING, 2014–2028
FIGURE 24 REVENUE SHIFT & NEW POCKETS FOR HIGH-THROUGHPUT SCREENING (HTS) SOLUTION PROVIDERS
FIGURE 25 PRICING TREND FOR INSTRUMENTS, 2021–2023
FIGURE 26 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING PRODUCT DEVELOPMENT PHASE
FIGURE 27 DIRECT DISTRIBUTION—STRATEGY PREFERRED BY PROMINENT COMPANIES
FIGURE 28 ECOSYSTEM ANALYSIS: HIGH-THROUGHPUT SCREENING MARKET
FIGURE 29 TOP APPLICANTS & OWNERS (COMPANIES) FOR HIGH-THROUGHPUT SCREENING PATENTS (JANUARY 2012–DECEMBER 2023)
FIGURE 30 HIGH-THROUGHPUT SCREENING MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 31 KEY BUYING CRITERIA FOR END USERS
FIGURE 32 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET SNAPSHOT
FIGURE 33 ASIA PACIFIC: HIGHT-THROUGHPUT SCREENING (HTS) MARKET SNAPSHOT
FIGURE 34 REVENUE ANALYSIS OF KEY PLAYERS, 2021–2023 (USD MILLION)
FIGURE 35 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2023
FIGURE 36 HIGH-THROUGHPUT SCREENING (HTS) MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
FIGURE 37 HIGH-THROUGHPUT SCREENING (HTS) MARKET: COMPANY FOOTPRINT
FIGURE 38 HIGH-THROUGHPUT SCREENING (HTS) MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
FIGURE 39 EV/EBITDA OF KEY VENDORS
FIGURE 40 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 41 HIGH-THROUGHPUT SCREENING (HTS) MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 42 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
FIGURE 43 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023)
FIGURE 44 MERCK KGAA: COMPANY SNAPSHOT (2023)
FIGURE 45 DANAHER CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 46 REVVITY, INC.: COMPANY SNAPSHOT (2023)
FIGURE 47 TECAN GROUP LTD. COMPANY SNAPSHOT (2023)
FIGURE 48 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2023)
FIGURE 49 CORNING INCORPORATED: COMPANY SNAPSHOT (2023)
FIGURE 50 METTLER-TOLEDO INTERNATIONAL INC.: COMPANY SNAPSHOT (2023)
FIGURE 51 LONZA GROUP: COMPANY SNAPSHOT (2023)
FIGURE 52 WATERS CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 53 SARTORIUS AG: COMPANY SNAPSHOT (2023)
FIGURE 54 EPPENDORF SE: COMPANY SNAPSHOT (2023)
FIGURE 55 PORVAIR PLC: COMPANY SNAPSHOT (2023)
FIGURE 56 GREINER AG: COMPANY SNAPSHOT (2023)
FIGURE 57 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT (2023)
FIGURE 58 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2023)

This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global high-throughput screening (HTS) market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

The secondary sources referred to for this research study include publications from government sources, such as World Health Organization (WHO), American Society for Clinical Laboratory Science (ASCLS), Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), National Center for Biotechnology Information (NCBI), American Association for Clinical Chemistry (AACC), American Society for Pharmacology and Experimental Therapeutics (ASPET), National Health Service (NHS), Pharmaceuticals and Medical Devices Agency (PMDA), European Medicines Agency (EMA), and Center for Translational Research among others. Corporate and regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations were also used as secondary sources for this research report. Secondary data was collected and analyzed to arrive at the overall size of the global high-throughput screening (HTS) market, which was validated through primary research.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global high-throughput screening (HTS) market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as personnel from pharmaceutical and biopharmaceutical industries, CMOs and CROs, academic & research institutes, and experts from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. These interviews were conducted across four major regions, including the Asia Pacific, North America, Europe, Latin America, and the Middle East & Africa. Approximately 80% and 20% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

The following is a breakdown of the primary respondents:

High-Throughput Screening  (HTS) Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The global size of the market was estimated through multiple approaches. A detailed market estimation approach was followed to estimate and validate the value of the high-throughput screening (HTS) market and other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and market have been identified through extensive primary and secondary research.
  • The revenues generated from the high-throughput screening (HTS) business of leading players have been determined through primary and secondary research.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

High-Throughput Screening  (HTS) Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Data Triangulation

After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Market Definition

High-throughput screening (HTS) is a drug discovery process that involves automated testing of large quantities of chemical or biological compounds against specific biological targets using various binding assays. This method is widely used in the pharmaceutical industry and utilizes robotics, automation, liquid handling devices, plate readers, and specialized software for instrument control and data processing. High-throughput screening (HTS) is a drug discovery process that involves automated testing of large quantities of chemical or biological compounds against specific biological targets using various binding assays. This method is widely used in the pharmaceutical industry and utilizes robotics, automation, liquid handling devices, plate readers, and specialized software for instrument control and data processing.

Stakeholders

  • Contract research organizations
  • Pharmaceutical & biopharmaceutical companies
  • Academic & research institutes
  • High-throughput screening instrument & reagent manufacturers
  • High-content screening database, service, and software providers
  • Venture capitalists & investors
  • Market research & consulting firms
  • Government associations
  • Medical institutions & universities

Report Objectives

  • To define, describe, and forecast the global high-throughput screening (HTS) market based on offerings, technology, application, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa
  • To profile the key players and comprehensively analyze their product & service portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as acquisitions, product/ service launches, expansions, agreements, partnerships, and collaborations in the market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Geographical Analysis

  • Further breakdown of the Rest of Europe high-throughput screening (HTS) market, by country
  • Further breakdown of the Rest of Asia Pacific high-throughput screening (HTS) market, by country
  • Further breakdown of the Rest of Latin America and Middle East & Africa high-throughput screening (HTS) market, by country

Company Information

  • Detailed analysis and profiling of additional market players (up to five)
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
BT 2220
Published ON
Jul, 2024
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the High Throughput Screening Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
knowledgestore logo

Want to explore hidden markets that can drive new revenue in High Throughput Screening Market?

Find Hidden Markets
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status
Website Feedback